|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | Case study on the effect of T-AYU-HM Premium along with modern medicines in Covid-19 patient with comorbidities |
| Authors Name: | Atul Desai , Kavita Desai , Hemshree Desai , Rutvij Desai , Chirag Desai |
| Unique Id: | IJSDR2108007 |
| Published In: | Volume 6 Issue 8, August-2021 |
| Abstract: | Patients with existing comorbidities or those who are elderly have a poor prognosis. Generally, existing comorbidities in covid-19 patients exhibit increased chances of mortality and require a longer treatment period. This pandemic has now reached a stage where there is a dire need to incorporate an integrated treatment approach for combating such conditions. Here, we present a case study on the clinical outcome of the integrated treatment approach in Covid-19 patients with pre-existing comorbidities. The patient is a known case of type 2 diabetes mellitus, hypertension, hypothyroidism, and arthritis. He was on his medication at the time. On infection with coronavirus, he was advised of the standard treatment plan and strict home quarantine. He presented to the covid-19 healthcare center with complaints of weakness, breathlessness on exertion, cough, loss of appetite. On examination, he had a 93% oxygen saturation and had hematological findings; CRP 33.3(mg/dL), ESR 112(mm/hour), D-dimer 2470(ng/mL), LDH 2485 (Units/L), RBS 596 mg/d. He provided his informed consent to proceed with the integrated treatment approach. The integrated treatment approach along modern medicine includes T-AYU-HM Premium 600mg and Acupen 600mg thrice a day. The treatment plan has resulted in remarkable improvement in the clinical profile and the inflammatory markers of patients. It has managed the blood glucose level in the patient and preventing unwanted complications associated with it. This case study provides information about the importance of an integrated treatment approach in the treatment of Covid-19 with existing co-morbidities. |
| Keywords: | Covid-19, T-AYU-HM Premium, D-Dimer, CRP, ESR, Comorbidities |
| Cite Article: | "Case study on the effect of T-AYU-HM Premium along with modern medicines in Covid-19 patient with comorbidities", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.6, Issue 8, page no.38 - 41, August-2021, Available :http://www.ijsdr.org/papers/IJSDR2108007.pdf |
| Downloads: | 000338720 |
| Publication Details: | Published Paper ID: IJSDR2108007 Registration ID:193582 Published In: Volume 6 Issue 8, August-2021 DOI (Digital Object Identifier): Page No: 38 - 41 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn